ConductScience.org, home

Paper27210751

Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model.

Hamilton A and 5 others. Cell Rep, 2016. Cited by 94 papers, by iCite.

Cite this record

ConductScience Library. Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model. Papers, record 27210751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27210751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model.
PubMed
Journal
Cell Rep
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
94
iCite
Relative citation ratio, by iCite
3.38
iCite
Revised in PubMed
2017-11-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hamilton AAlison
2Vasefi MMaryam
3Vander Tuin CCheryl
4McQuaid RJRobyn J
5Anisman HHymie
6Ferguson SSStephen S G

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Cognitive DysfunctionMajor topic
ImidazolesMajor topic
PyridinesMajor topic
Receptor, Metabotropic Glutamate 5Major topic
Amyloid beta-Peptides
Animals
Disease Models, Animal
Memory
Mice, Inbred C57BL
Mice, Transgenic
Plaque, Amyloid

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MOP-119437CIHRCanadaPubMed

Source PubMed

Download CSV of grants

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.

PMIDTitleJournalYearIn PapersSource
42745993Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy?Mol Neurodegener Adv2026https://conductscience.org/library/papers/42745993PubMed
42645765Calcium dysregulation in neurovascular function in Alzheimer's disease: mechanisms, therapeutic targets.Geroscience2026https://conductscience.org/library/papers/42645765PubMed
41606687Presymptomatic pharmacological inhibition of mGluR5 improves survival in a mouse model of prion diseases.Acta Neuropathol Commun2026https://conductscience.org/library/papers/41606687PubMed
41097999Combined Treatment with Minocycline and an mGluR5 Antagonist Alters Resting EEG Spectral Power, but Not Sound-Evoked Responses, in a Mouse Model of Fragile X Syndrome.ASN Neuro2025https://conductscience.org/library/papers/41097999PubMed
41073451Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson's disease.NPJ Parkinsons Dis2025https://conductscience.org/library/papers/41073451PubMed
41025328Modeling presynaptic inhibition by the amyloid precursor protein demonstrates one potential mechanism for preventing runaway synaptic modification in Alzheimer's disease.Alzheimers Dement2025https://conductscience.org/library/papers/41025328PubMed
40388923The interaction between neurotransmitter receptor activity and amyloid-β pathology in Alzheimer's disease.J Alzheimers Dis2025https://conductscience.org/library/papers/40388923PubMed
40329311Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer's disease: a multi-tracer PET study.Alzheimers Res Ther2025https://conductscience.org/library/papers/40329311PubMed
40047257Genetic and pharmacologic enhancement of SUMO2 conjugation prevents and reverses cognitive impairment and synaptotoxicity in a preclinical model of Alzheimer's disease.Alzheimers Dement2025https://conductscience.org/library/papers/40047257PubMed
39974631Unveiling the Interplay: Neurovascular Coupling, Astrocytes and G Protein-Coupled Receptors in Alzheimer's Disease.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/39974631PubMed
39353038Amyloid-β oligomers trigger sex-dependent inhibition of GIRK channel activity in hippocampal neurons in mice.Sci Signal2024https://conductscience.org/library/papers/39353038PubMed
39214708Cells and Molecules Underpinning Cannabis-Related Variations in Cortical Thickness during Adolescence.J Neurosci2024https://conductscience.org/library/papers/39214708PubMed
38941064Interactions between metabotropic glutamate and CB1 receptors: implications for mood, cognition, and synaptic signaling based on data from mGluR and CB1R-targeting drugs.Pharmacol Rep2024https://conductscience.org/library/papers/38941064PubMed
38217040Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer's disease: A [18F]PSS232 PET/MRI study.Alzheimers Res Ther2024https://conductscience.org/library/papers/38217040PubMed
38053635Amyloid-β1-42 oligomers enhance mGlu5R-dependent synaptic weakening via NMDAR activation and complement C5aR1 signaling.iScience2023https://conductscience.org/library/papers/38053635PubMed
38012296Targeting synapse function and loss for treatment of neurodegenerative diseases.Nat Rev Drug Discov2024https://conductscience.org/library/papers/38012296PubMed
37759748Functional Interaction between Adenosine A2A and mGlu5 Receptors Mediates STEP Phosphatase Activation and Promotes STEP/mGlu5R Binding in Mouse Hippocampus and Neuroblastoma Cell Line.Biomolecules2023https://conductscience.org/library/papers/37759748PubMed
37566031Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes.Cells2023https://conductscience.org/library/papers/37566031PubMed
37055181VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.J Neurosci2023https://conductscience.org/library/papers/37055181PubMed
36982982Co-Expression Network Analysis Identifies Molecular Determinants of Loneliness Associated with Neuropsychiatric and Neurodegenerative Diseases.Int J Mol Sci2023https://conductscience.org/library/papers/36982982PubMed

See all 58 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
APP351PubTator's text mininghttps://conductscience.org/library/genes/351

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27210751

GET https://conductscience.org/api/papers/v1/27210751/cited_by?page=2